Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2007
05/30/2007CN1969957A Pharmaceutical composition comprising flavescent sophora root, magnolia vine fruit and astragalus root
05/30/2007CN1969952A Antivirus Chinese medicinal formulation, preparation process, quality control method and use thereof
05/30/2007CN1969940A Antivirus pharmaceutical composition
05/30/2007CN1969937A Pharmaceutical composition for treating hepatitis
05/30/2007CN1969936A Glochidion puberum (Linn.) Hutch.
05/30/2007CN1969935A Dietary formulation for supplementary treatment of hepatitis
05/30/2007CN1969924A Pharmaceutical composition of Silibinin and isatis root
05/30/2007CN1969923A Antivirus extract of isatis root, its extraction method, use and content assaying method
05/30/2007CN1969922A Compound pharmaceutical composition and preparation process thereof
05/30/2007CN1969896A Anti-hepatitis pharmaceutical composition and preparation process thereof
05/30/2007CN1969887A Method for extracting propolis functional ingredient by using microwave technology
05/30/2007CN1969880A Medicinal powder for treating beriberi
05/30/2007CN1969879A Medicament for treating bacteria or virus infected disease of aquatic cultured animals
05/30/2007CN1969878A Medicament for treating bacteria or virus infected disease of aquatic cultured animals
05/30/2007CN1969877A Povidone iodine powder and preparation process thereof
05/30/2007CN1969876A Lyophilized injection of lentinan and preparation process thereof
05/30/2007CN1969875A Process for preparing clindamycin phosphate injection
05/30/2007CN1969872A Method for preparing colon targeted pill of lincomycin used for poultry and livestock
05/30/2007CN1969868A Method for preparing colon targeted pill of tylosin used for poultry and livestock
05/30/2007CN1969867A Method for preparing colon targeted pill of tilmicosin used for poultry and livestock
05/30/2007CN1969866A Method for preparing colon targeted pill of amikacin used for poultry and livestock
05/30/2007CN1969865A Method for preparing colon targeted pill of doxycycline used for poultry and livestock
05/30/2007CN1969864A Method for preparing colon targeted pill of sulfamonomethoxine used for poultry and livestock
05/30/2007CN1969860A Method for preparing colon targeted pill of ofloxacin used for poultry and livestock
05/30/2007CN1969856A Usage of caffeine and its analogue in resistance of hepatitis B replication and use thereof in preparation of medicament for treating viral hepatitis
05/30/2007CN1969852A Method for preparing colon targeted pill of rifampicin used for poultry and livestock
05/30/2007CN1969851A Method for preparing colon targeted pill of enrofloxacin used for poultry and livestock
05/30/2007CN1969850A Taste masked suspension prescription for treating infant cold and method for preparing same
05/30/2007CN1969846A Pharmaceutical composition of mecillinam sodium and beta-lactamase inhibitor
05/30/2007CN1969845A Oral formulation of amoxicillin and sulbactam pivoxyl and preparation method thereof
05/30/2007CN1969844A Method for preparing colon targeted pill of amoxicillin used for poultry and livestock
05/30/2007CN1969838A Micro-ecological preparation for treating moniliasis
05/30/2007CN1969837A Method for preparing colon targeted pill of tiamulin used for poultry and livestock
05/30/2007CN1969834A Method for preparing colon targeted pill of florfenicol used for poultry and livestock
05/30/2007CN1969833A Dry powder composition containing CoQ10 and preparation process thereof
05/30/2007CN1969830A Itraconazole liposome and preparation process thereof
05/30/2007CN1969653A Antivirus microbe additive for silkworm and preparation method thereof
05/30/2007CN1318596C Vectors based on recombinant defective viral gene group, and their use in formulation of vaccines
05/30/2007CN1318580C Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method
05/30/2007CN1318576C Targeted cytolysis of HIV-infected cells by chimerical CD4 receptor bearing cells
05/30/2007CN1318573C Mycobacterium smegmatis preparation and use thereof
05/30/2007CN1318450C Modified/chimeric super-antigens and their use
05/30/2007CN1318449C Application of anti SARS specificity IgY in preparation dor preventing and treating SARS
05/30/2007CN1318446C Transferrin receptor protein of Moraxella
05/30/2007CN1318441C Macrilides ketolide compound, and its preparing method and use
05/30/2007CN1318424C Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine
05/30/2007CN1318421C Non-nucleoside reverse transcriptase inhibitors
05/30/2007CN1318420C Dipyridodiazepinones as reverse transcriptase inhibitors
05/30/2007CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/30/2007CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same
05/30/2007CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
05/30/2007CN1318102C Medical devices containing rapamycin analogs
05/30/2007CN1318092C Immunity treatment composition containing antibody-cytokine fusion protein mediated and angiogenesis inhibitor
05/30/2007CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases
05/30/2007CN1318084C Neuroprotective peptides
05/30/2007CN1318081C Ant oil liniment and its preparing method
05/30/2007CN1318077C Antivirus Chinese medicine compound preparation and its preparation method and use
05/30/2007CN1318050C Chinese medicine for treating hepatitis B and preparation method thereof
05/30/2007CN1318040C Method for producing medicine egg for treating child lymph tuberculosis
05/30/2007CN1318038C Medicine for treating recurrent psoriasis and its preparing process
05/30/2007CN1318033C Cefuroxime sodium and sulbactam sodium composition for injection
05/30/2007CN1318031C Compositions containing benzoxazinone and nucleoside like materials
05/30/2007CN1318019C Solid dispersion comprising two different polymer matrixes
05/29/2007US7223867 Preparation of benzosuberonylpiperidine compounds
05/29/2007US7223858 Truncated aggrecanase molecules
05/29/2007US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis
05/29/2007US7223837 Anticancer prodrugs, enhance enzymatic activation rates
05/29/2007US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation
05/29/2007US7223790 Dimeric compounds and their use as anti-viral agents
05/29/2007US7223785 Viral polymerase inhibitors
05/29/2007US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
05/29/2007US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets
05/29/2007US7223778 5-substituted-2-arylpyridines
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/29/2007US7223773 Having antibacterial effect on gram-positive bacteria, gram-negative bacteria or anaerobic bacteria
05/29/2007US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies
05/29/2007US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity
05/29/2007US7223760 Substituted triazole compounds
05/29/2007US7223759 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains
05/29/2007US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer
05/29/2007US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
05/29/2007US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1
05/29/2007US7223593 Anticancer agents; gene coding immunomoderator cytokine protein
05/29/2007US7223585 Viral purification methods
05/29/2007US7223411 Administering a mutated herpesvirus having a mutation in genes encoding a protein essential for viral genome replication to render the herpesvirus replication defective; effecting an antibody subclass shift of IgG2a/IgG upon in vivo administration
05/29/2007US7223398 Population of conjugate molecules of an allergen and a polynucleotide comprising an immunostimulatory sequence; polynucleotide conjugated, or attached, to antigens
05/29/2007US7223394 Human antibodies that bind human TNFα
05/29/2007CA2268758C Immunogenic detoxified mutant e. coli lt-a toxin
05/29/2007CA2258679C Solid solution of an antifungal agent with enhanced bioavailability
05/29/2007CA2236998C Tissue-specific and target rna-specific ribozymes
05/29/2007CA2168080C Process for the preparation of 1-(2'-deoxy-2',2'-difluoro- d-ribopentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro- beta-d-ribo-pentopyranose
05/24/2007WO2007059421A2 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same
05/24/2007WO2007059356A2 Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1
05/24/2007WO2007059229A1 Hiv integrase inhibitors
05/24/2007WO2007058894A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
05/24/2007WO2007058646A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
05/24/2007WO2007058625A1 Toxin-antitoxin system and applications thereof
05/24/2007WO2007058392A1 Heterocyclic compound and medicinal application thereof
05/24/2007WO2007058384A1 Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same
05/24/2007WO2007058322A1 Basic group-containing compound and use thereof